12,478 press releases in English indexed under finance.
LOS ANGELES, October 07, 2026--Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, today announced that it will release its second quarter results for the 2027 fiscal year on Wednesday, October 28, 2026, after the close of trading on the New York Stock Exchange. Houlihan Lokey will host a conference call at 5:00 p.m.
CHARLOTTE, N.C., October 07, 2026--Six Flags Entertainment Corporation (NYSE: FUN), the largest regional amusement park operator in North America, said today it will issue 2026 third-quarter results in the pre-market hours of Thursday, November 5, 2026.
RESEARCH TRIANGLE PARK, N.C., October 07, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today at TechIQ 2026 introduced IQVIA Explorer™ to help customers make better-informed commercial decisions.
DENVER, October 07, 2026--Ibotta, Inc. (NYSE: IBTA), North America’s leading digital promotions network, announced today that it will report third quarter 2026 financial results after the market closes on November 2, 2026. Management will host a conference call and webcast to discuss Ibotta’s financial results, recent developments, and business outlook at 2:30 p.m.
NEW YORK, October 07, 2026--Blackstone Mortgage Trust, Inc. (NYSE: BXMT) (the "Company") today announced that it will publish its third-quarter 2026 earnings presentation on its website at www.bxmt.com and file its Form 10-Q pre-market on Thursday, October 29, 2026. The Company will also host a conference call the same day at 9:00 a.m.
NEW YORK, October 07, 2026--MetLife, Inc. (NYSE: MET) will release its third quarter 2026 financial results on Wednesday, November 4, 2026, after the market closes. The earnings news release, financial supplement and related materials will be posted on MetLife’s Investor Relations webpage at investor.metlife.com.
HOUSTON, October 07, 2026--Camden Property Trust (NYSE:CPT) (the "Company") announced today that its third quarter 2026 earnings will be released after the market closes on Thursday, November 5, 2026. The Company will host a conference call on Friday, November 6, 2026, at 10:00 AM Central Time, which will include prepared remarks by management and a question-and-answer session. Camden’s complete earnings release and supplemental data will be available in the Investors section of the Company’s we
Today, Levi Strauss & Co. announced Q3 FY26 financial results, delivering another quarter of solid growth while continuing to improve profitability. The results demonstrated the strength of our diversified portfolio and reinforced our confidence in our strategies. “Our third-quarter performance highlighted the power of our diversified portfolio and reinforced our confidence that we have the… The post Top Takeaways for Our Q3’26 Earnings appeared first on Levi Strauss & Co.
HARTFORD, Conn., October 07, 2026--Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ) (the "Fund") today announced the final results of its previously announced tender offer ("Tender Offer") to acquire up to 25% of its outstanding shares. The Tender Offer expired October 5, 2026, at 5:00 p.m. (Eastern).
ONTARIO, Calif., October 07, 2026--Prime Healthcare Services will post earnings on Friday November 13th, to be followed by a conference call on November 16th at 2:00 p.m. (ET) to discuss the reported results.
DALLAS, October 07, 2026--Resources Connection, Inc. (Nasdaq: RGP) (the "Company"), a professional services firm, today announced its financial results for its first quarter of fiscal 2027 ended August 29, 2026.
ALISO VIEJO, Calif., October 07, 2026--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced today positive topline results from a long-term Phase 3 extension study (GLK-202-03) evaluating the durability, visual outcomes, and safety of Epioxa®, the company's groundbreaking epi-on corneal cross-linking therapy for the treatment of keratoconus, a sigh